Ryan Fukushima

Michigan Ross Zell Lurie Institute / Venture Capital/ (Zell Lurie Institute) is a venture capital subsidiary of Zell Lurie Institute for Entrepreneurial Studies Studies founded in 1997 by Samuel Zell, Ann Lurie and Robert H. Lurie. The firm is headquartered in Ann Arbor, Michigan.

TechStars Central LLC (TechStars) is an Independent Accelerator Incubator firm founded in 2006. The firm is headquartered in the US..

Tapjoy, Inc. provides social and mobile applications. The firm operates as a mobile performance-based advertising platform that drives deep engagement and monetization opportunities for app publishers, while delivering valuable, engaged consumers to some of the brand advertisers. It has locations in Atlanta, Beijing, Boston, Chicago, London, Los Angeles, New York, Santa Barbara, San Francisco, Seoul, Shanghai and Tokyo. The company was founded by Ben Lewis, Shukla Anu, Lee Linden and Mitch Liu in 2007 and is headquartered San Francisco, CA.

Lightbank LLC (Lightbank) is a venture capital firm founded in 2010 by Eric Paul Lefkofsky and Bradley A. Keywell. The firm is headquartered in Chicago, Illinois.

Huron River Venture Partners LLC (Huron River Venture) is a venture capital firm founded in 2010 by Ryan Waddington and Tim Streit. The firm is headquartered in Ann Arbor, Michigan.

Hyde Park Venture Partners Management LLC (Hyde Park Venture Partners) is a venture capital firm founded in 2011 by Guy Turner. The firm is headquartered in Chicago, Illinois.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA.

The American company was founded by Ryan Fukushima and Eric Paul Lefkofsky, with Ryan Fukushima serving as the CEO since incorporation. Pathos AI leverages the power of AI technologies, multimodal real-world data, and patient-derived biological models to bring precision medicines to market through partnerships with biopharmaceutical companies. The company is focused on re-engineering drug development with the power of advanced AI technologies and has built a proprietary platform and operating model called Pathos to gain crucial insights and act on them at scale.